Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Incyte
INCY · XNAS
$122.65
-0.51%
-$0.63
Key metrics
52-week range
$10.75 - $1.00
Close price
$123.28
Market cap
$25B
P/E ratio
15.7
Beta
0.38
About the company
Incyte Genomics Inc
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$131
11
Buy
/ 21
Recent calls
08/31/2026
BMO Capital
Evan Seigerman
Hold · Price target $130
09/01/2026
H.C. Wainwright
Mitchell Kapoor
Buy · Price target $150
08/21/2026
Canaccord Genuity
John Newman
Buy · Price target $152
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna democrat · House · CA-17 spouse |
| $5,003/$40,002/$75,000 |
#2Ro Khanna democrat · House · CA-17 child |
| $2,001/$16,001/$30,000 |
#3Ro Khanna democrat · House · CA-17 self |
| $2,001/$16,001/$30,000 |
#4Rob Bresnahan republican · House · PA-8 self |
| $1,001/$8,001/$15,000 |
#5Donald J Trump republican · Executive self |
| 8/70/131 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app